FDA near decision on Vietnam basa catfish ban

GARRY MITCHELL
Associated Press

MOBILE, Ala. - The U.S. Food and Drug Administration is nearing its decision on banning basa catfish from Vietnam, which has already been taken off the shelves in three Southeastern states.

FDA spokesman Mike Herndon said Thursday a decision could come next week on how the agency will rule on the multimillion-dollar catfish imports. The agency is under pressure from an Arkansas congressman for a nationwide ban.

"Right now it's a state issue," Herndon said in a telephone interview from FDA's office in Rockville, Md.

Alabama, Mississippi and Louisiana banned Vietnam basa catfish after officials detected antibiotics given to prevent disease in Vietnamese fish.

Herndon said FDA has the option of issuing an import alert or seizing the product "or a combination of both."

If an import alert is issued, he said, any future basa fish from those areas of the world would not be allowed into the United States. "FDA will make a determination in the next week or so what we're doing to do with it," he said.

U.S. Rep. Mike Ross, D-Ark., this week asked the FDA to temporarily ban the sale of basa catfish from Vietnam nationwide because of the health concerns. As of Thursday, Arkansas had not banned the product.

The antibiotic at issue is not allowed in food in the United States, Canada and Europe out of concern that the germs the antibiotic fights would become resistant, making the antibiotic less effective when given to humans to fight infections.

The basa samples that led to the state bans contained ciprofloxacin and enrofloxacin, which are antibiotics that transfer resistant microorganisms to humans and lead to the development of the infectious disease Campylobacter, which can cause diarrhea, cramping, abdominal pain and fever.

Ho Quoc Luc, president of the Vietnam Association of Seafood Exporters and Producers, said in a statement Wednesday the state bans would not have a major impact on catfish exports to the U.S. because they don't import that much product.

However, he warned that if the issue is not resolved then public opinion about Vietnamese catfish could hurt sales.

Luc said Vietnam worked hard to meet the seafood safety standards set by customers, but could not rule out that antibiotics were used by catfish farmers.

Catfish exports to the United States were badly affected after the U.S. imposed a tariff of up to 64 percent two years ago following a lawsuit filed against Vietnamese catfish farmers, claiming they had dumped the fish on the American market at lower than market price.

Luc said Vietnam has expanded its catfish markets to Europe and the Middle East since then.

Alabama Agriculture Commissioner Ron Sparks said he's concerned that a consumer might be allergic to the antibiotic. Alabama's ban affected about 25 tons of imported farmed seafood, Sparks said earlier this month.

On Thursday, Sparks said his department's Aug. 12 stop sale order involves giving notice to warehouses that they are to hold their Vietnamese imports for sample testing until further notice. A recall of products from retail markets and restaurants has not been issued, but could be if testing shows positive results.

In Louisiana, 355.5 tons of Vietnamese seafood has been taken off shelves. Mississippi's agriculture commissioner, Lester Spell, also banned the product.

"I strongly urge consumers to stay away from basa fish products," Spell said in a statement Tuesday. Basa samples collected in Mississippi are being tested at the Mississippi State Chemical Laboratory in Starkville. Results of that testing are not yet available. But Mississippi issued its ban based on findings in Louisiana involving two Vietnamese fish processors.

Infinity Seafoods Inc. CEO Andrew Forman of Boston, Mass., who imports basa catfish from Vietnam, said, "The problem is the benchmark price of domestic catfish is high. Basa has proven to be a viable alternative. It is a price war."

Most U.S. farm-raised catfish are produced in the Southeastern states.

According to the Mississippi-based Catfish Institute, basa catfish is not raised under the same high standards as U.S. farm-raised catfish. Federal reports show that sales of U.S. farm-raised catfish totaled 300 million pounds in 2004, compared to basa sales of 9 million pounds for that year.

Louisiana Recalls and Stops Sale of Some 700,000 Pounds of Fish from Vietnam Pending Investigation Into Use of Antibiotic Banned by the FDA in July

Date Published: August 17, 2005
Source: Newsinferno.com News Staff

Commissioner of Agriculture and Forestry Robert Odom announced on Monday that nearly 350 tons (700,000 pounds) of Vietnamese seafood has been taken off the market since Friday and remain must remain frozen until it can be analyzed for an antibiotic that is not allowed in food.

Inspectors are checking cold storage facilities, seafood markets, restaurants, grocery stores, and other retail establishments, looking for any basa catfish, crab meat, and any other seafood products from Vietnam.

Odom stopped the sale of all seafood from Vietnam on Friday after the FDA found the antibiotic fluoroquinolones in imported basa catfish. The catfish were bought in Louisiana under the LA Fish Co. label.

Such antibiotics are sometimes added to seafood in other countries and are used to treat tuberculosis, pneumonia and other infections in people. The antibiotics will not cause illness but are not allowed in United States, Canadian, and European food because germs could become resistant to them.

Odom stated in a news release: "We're going from location to location making sure we find it all. We're not trying to disrupt business or treat anyone unfairly, we are enforcing the law. There is a reason the FDA has a zero-tolerance for this antibiotic and it's to protect you and me and our children and grandchildren."

Only last month, the U.S. Food and Drug Administration (FDA) announced a final decision to no longer allow distribution or use of the antimicrobial drug enrofloxacin (Baytril) for the purpose of treating bacterial infections in poultry.

This animal drug belongs to a class of drugs known as fluoroquinolones and is marketed under the name Baytril by Bayer Corporation. The drug is in the same "family" as Cipro, the widely used human antibiotic.

The FDA finally made a decision which many infectious disease experts had been calling for and directed its Center for Veterinary Medicine (CVM) to begin proceedings to withdraw use of this animal drug in poultry.

The FDA now acknowledges scientific data shows that the use of enrofloxacin in poultry caused resistance to emerge in Campylobacter, a bacterium that causes foodborne illness. Chickens and turkeys normally harbor Campylobacter in their digestive tracts without causing poultry to become ill.

Enrofloxacin does not completely eliminate Campylobacter from the birds' intestinal tracts, and those Campylobacter bacteria that survive are resistant to fluoroquinolone drugs. These resistant bacteria multiply in the digestive tracts of poultry and persist and spread through transportation and slaughter, and are found on chicken carcasses in slaughter plants and retail poultry meats.

Campylobacter bacteria are a significant cause of foodborne illness in the U.S. Antimicrobial treatment is recommended for people with severe illness as well as the very young, the elderly, and people with certain medical conditions.

Complications of such infections can include reactive arthritis and, more rarely, blood stream infections. Early treatment can mitigate symptoms and may decrease the risk of complications.

Fluoroquinolones used in humans are ineffective if used to treat Campylobacter infections that are resistant to them. This failure can significantly prolong the duration of the infections and may increase the risk of complications. The proportion of Campylobacter infections that are resistant to fluoroquinolones has increased significantly since the use of enrofloxacin in poultry was approved in the U.S.

Bayer Corporation has been given 60 days to appeal the withdrawal. The final order withdrawing approval of the antimicrobial drug enrofloxacin for the purpose of treating bacterial infections in poultry will become effective on September 12, 2005.

The Final Decision can be found at www.fda.gov/oc/antimicrobial/baytril.pdf.

This ruling is seen as a step forward in the battle to stem the tide of antibiotic-resistant bacteria that are rapidly becoming a public health crisis. Critics of the FDA's inactivity on the matter have praised this first, decisive measure to deal with the problem.

Thus, the recall of the seafood from Vietnam, which may have been treated with this very same antibiotic, is merely an extension of last month's decision by the FDA. "If we can't use these substances in U.S. food production, then countries we do business with shouldn't use them either. We all have to abide by the same rules," Odom said.